跳至主要内容
临床试验/IRCT20160905029714N2
IRCT20160905029714N2招募中3 期

evaluation of the effect of Donepezil in comparison with dual combination of Donepezil and Betahistine in improvement of children with autism spectrum disorder - a randomized clinical trial

Tehran University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
6 years 至 18 years(—)
性别
All

入选标准

  • All children and adolescents aged 6-18 years with autism spectrum disorder whose diagnosis has been confirmed by a child and adolescent psychiatrist.
  • Patients in a relative remission over the past 4 weeks and no dose adjustment was required.
  • If there is other comorbid psychiatric disorders, they should be controlled and not in the acute phase of the disease

排除标准

  • If there is a concomitant genetic disorder, seizure or medical illness, these people will be excluded from the study
  • If comorbid psychiatric disorders recur during the study, the individuals will be excluded from the study.
  • Patients who change their medication regimen or dose during the 4 weeks before the start of the trial or during the entire trial period will also be excluded from the study
  • Patients who do not tolerate the intended dose or experience a serious complication will be excluded from the study.

研究者

相似试验